Erleada 240 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F9AB6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,236
Award facts
- Contract value 100% obligated
- $14,236.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14.24K delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 25, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company has demonstrated its capability to meet federal procurement requirements through open competition, with an extensive portfolio of delivery orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare supplies across multiple therapeutic domains. This delivery order for Erleada, a cancer treatment medication, reflects the company's ongoing role in supplying specialized pharmaceutical products to support the Defense Health Agency and other government healthcare systems through the DLA's flexible contract vehicle.
Quick answers
Who was awarded contract SPE2DR26F9AB6?
SPE2DR26F9AB6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26F9AB6 worth?
The government has obligated $14,236 on SPE2DR26F9AB6.
Is contract SPE2DR26F9AB6 an order under another contract?
Yes. SPE2DR26F9AB6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AB6 competed?
The extent of competition for SPE2DR26F9AB6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award